Fact CheckerSign in

NCT07648277Recruiting

Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple Sclerosis

Relationship Between Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 15 Jun 2026

Brief summary (registry, in English)

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal degeneration. Neuromuscular impairments associated with MS, including muscle weakness, spasticity, fatigue, and proprioceptive deficits, may lead to alterations in spinal posture and reduced spinal mobility. These changes can negatively affect trunk control, balance, respiratory function, and functional independence. Although postural abnormalities and mobility limitations have been reported in individuals with MS, the relationship between spinal posture, spinal mobility, and balance remains insufficiently investigated. Therefore, this study aims to examine the associations between spinal posture, spinal mobility, and balance performance in individuals with multiple sclerosis. Improved understanding of these relationships may contribute to the development of targeted rehabilitation interventions aimed at enhancing postural control and functional outcomes in this population. This study further hypothesises that alterations in spinal posture and spinal mobility are associated with impaired balance performance in individuals with multiple sclerosis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
10 Jun 2026
Start date
Feb 2026
Primary completion date
Jun 2026
Lead sponsor
Ankara Yildirim Beyazıt University
NCT number
NCT07648277

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From Feb 2026 to the primary completion date, Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receipt of corticosteroid treatment within the previous 4 weeks

Other illness

  • Presence of any additional neurological disorder
  • History of surgical intervention involving the lower extremities, spine, or abdominal region

Other

  • Spasticity defined as a Modified Ashworth Scale score ≥3

Who the study is looking for

  • Diagnosis of relapsing-remitting multiple sclerosis (RRMS)
  • Aged between 18 and 65 years
  • EDSS score between 0.5 and 4.5
  • Standardized Mini-Mental State Examination score ≥24

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Yıldırım Beyazıt University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.